NCT03400917 - Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

December 1, 2021

Study Completion Date

February 28, 2023

Conditions

Newly Diagnosed Glioblastoma

Interventions

BIOLOGICAL

AV-GBM-1

Investigational treatment with AV-GBM-1

Trial Locations (8)

Norton Cancer Institute, Louisville

John Wayne Cancer Institute, Santa Monica

Scripps Health, La Jolla

UC San Diego Moores Cancer Center, La Jolla

Hoag Memorial Hospital Presbyterian, Newport Beach

UC Irvine Medical Center, Orange

UC Davis Comprehensive Cancer Center, Sacramento

Rutgers Cancer Institute, New Brunswick